This bill amends existing newborn screening law (RCW 70.83.020, 70.83.023, and 70.83.030), adds a new section to chapter 70.83 RCW to establish rulemaking and procedures for the state newborn screening panel, and creates a new newborn screening revenue account in chapter 43.70 RCW. It requires the State Board of Health to reestablish the newborn screening panel in rule by January 1, 2027 and to conduct focused feasibility reviews and make determinations within specified timeframes when conditions are added to the federal recommended uniform screening panel (RUSP). The bill changes procedural requirements for specimen collection and handling (collection within 48 hours of birth and receipt by the Department of Health within 72 hours, excluding public health laboratory closure days), amends reporting duties to require labs and clinicians to report positive screening results, and confirms the Department of Health’s authority to charge a reasonable screening fee. On finance and administration, the bill authorizes a specific $8.40 fee per infant to be collected through the birthing facility to fund specialty clinics and certain support organizations, requires all receipts under chapter 70.83 RCW to be deposited into the newly created newborn screening revenue account, limits expenditures from that account to activities directly related to implementing chapter 70.83 RCW with only the secretary or designee authorized to approve expenditures, and makes the account subject to allotment procedures without requiring a separate appropriation. The act also reenacts and amends RCW 43.79A.040 to address how the state treasurer handles investments and distributes investment income, names many accounts (including the newborn screening revenue account) entitled to a proportionate share of earnings, and specifies that some accounts receive 80 percent of their proportionate share. The treasurer may commingle and invest funds under RCW 43.84.080 and use an investment income account to pay banking services prior to earnings distribution. Some statutory text and scheduling details are missing from the extracted material. The content of Section 7 as amended is not provided here (though Section 7 is noted to expire July 1, 2030), and full effective or expiration dates referenced in the bill header are not visible in the provided facts.

If enacted, the bill creates a clear, time‑bound process to bring Washington’s newborn screening closer to the federal recommended list: the State Board of Health must reestablish the state screening panel by January 1, 2027, perform focused feasibility reviews when the federal panel adds a condition, and complete rulemaking within defined months if it decides to include a condition. Practically, hospitals and birth attendants will need to collect a newborn blood specimen within 48 hours and get it to the Department of Health within 72 hours, and parents will typically be charged a screening fee (specified at $8.40 per infant) collected through the birthing facility; specialty clinics and some sickle cell outreach/support organizations are likely to see steadier funding from those fees. Financially, all receipts from newborn screening will be deposited into a new state treasurer account that the treasurer may invest and that is eligible to receive a proportionate share of investment earnings; expenditures from that account can be authorized by the secretary without a separate appropriation, which could speed program spending but concentrates spending control. Key implementation and fiscal details — including the full text and effects of the reenacted treasury provisions and the bill’s effective or expiration dates — are not included in the provided facts, so the timing and longer‑term budget impacts remain uncertain.